Surgery vs. Biopsy in the Treatment of Butterfly Glioblastoma: A Systematic Review and Meta-Analysis.
Shreya ChawlaVasileios K KavouridisAlessandro BoaroRasika KordeSofia Amaral MedeirosHeba EdreesElisabetta MezzaliraFrancesco SalaRania A MekaryTimothy R SmithPublished in: Cancers (2022)
Butterfly glioblastomas (bGBM) are grade IV gliomas that spread to bilateral hemispheres by infiltrating the corpus callosum. Data on the effect of surgery are limited to small case series. The aim of this meta-analysis was to compare resection vs. biopsy in terms of survival outcomes and postoperative complications. A systematic review of the literature was conducted using PubMed, EMBASE, and Cochrane databases through March 2021 in accordance with the PRISMA checklist. Pooled hazard ratios were calculated and meta-analyzed in a random-effects model including assessment of heterogeneity. Out of 3367 articles, seven studies were included with 293 patients. Surgical resection was significantly associated with longer overall survival (HR 0.39, 95%CI 0.2-0.55) than biopsy. Low heterogeneity was observed (I 2 : 0%). In further analysis, the effect persisted in extent of resection subgroups of both ≥80% and <80%. No statistically significant difference between surgery and biopsy was detected in terms of postoperative complications, although these were numerically larger for surgery. In patients with bGBM, surgical resection was associated with longer survival prospects compared with biopsy.
Keyphrases
- minimally invasive
- coronary artery bypass
- ultrasound guided
- fine needle aspiration
- systematic review
- surgical site infection
- end stage renal disease
- single cell
- newly diagnosed
- chronic kidney disease
- ejection fraction
- randomized controlled trial
- clinical trial
- big data
- machine learning
- peritoneal dialysis
- atrial fibrillation
- free survival
- double blind
- replacement therapy
- current status
- case report
- neural network